Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 6,619 | 779 |
| Receivables | 2,561 | 4,011 |
| Inventories | 857 | 735 |
| TOTAL | $10,165 | $5,559 |
| Non-Current Assets | ||
| PPE Net | 1,634 | 1,136 |
| Intangibles | 6,487 | 4,233 |
| Other Non-Current Assets | 20 | 20 |
| TOTAL | $8,141 | $5,389 |
| Total Assets | $18,306 | $10,948 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 116 | 233 |
| TOTAL | $1,631 | $1,757 |
| Non-Current Liabilities | ||
| Long Term Debt | 1,020 | 764 |
| Deferred Revenues | 616 | 316 |
| TOTAL | $1,556 | $800 |
| Total Liabilities | $3,187 | $2,557 |
| Shareholders' Equity | ||
| Common Shares | 18,267 | 9,976 |
| Retained earnings | -4,242 | -2,582 |
| TOTAL | $15,119 | $8,391 |
| Total Liabilities And Equity | $18,306 | $10,948 |